Completed
Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer
NCT03428126
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +12 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States